Updated:
InnoCal
Bryan Taylor established InnoCal to serve the exacting calibration needs of the aerospace, biomedical, and industrial sectors.
InnoCal
Bryan Taylor established InnoCal to serve the exacting calibration needs of the aerospace, biomedical, and industrial sectors. The firm's wealth origin is rooted in the operating business itself rather than a legacy financial windfall; it generates recurring revenue by maintaining and certifying thermocouples, RTDs, thermistors, and associated data-acquisition instruments. This makes InnoCal an operating company that functions as the central asset of a family office structure, rather than a diversified investment platform. InnoCal's strategy concentrates on precision temperature calibration and repair services compliant with ISO/IEC 17025 standards. The firm handles both benchtop and field calibrations, covering a measurement range from cryogenic to high-temperature thermal validation. Its primary deployable capital is reinvested into laboratory infrastructure — Fluke and Hart Scientific temperature baths, dry-block calibrators, and reference-grade SPRTs — alongside technician training. InnoCal's client base includes firms bound by FDA, FAA, and ISO 13485 quality mandates, creating a durable competitive moat around accreditation and audit-readiness. Geographically, the firm serves the Southern California industrial corridor, with customers across the United States that ship instruments to its Costa Mesa laboratory for certification. InnoCal's scale reflects its specialized footprint: a single headquarters laboratory professionally staffed by metrologists and quality managers. The firm's adjacent activities include on-site calibration services dispatched to client facilities, which extends its reach without adding brick-and-mortar overhead. The office structure remains lean, with no publicly disclosed private-equity or venture-capital vehicles spun out of the Taylor family's holdings. The concentration risk is offset by the non-discretionary nature of calibration spending in FDA-regulated manufacturing — medical-device and pharmaceutical production lines cannot operate without current calibration certificates. InnoCal's structural differentiator is its regulatory credentialing. A family office built entirely around an ISO/IEC 17025-accredited laboratory is rare; most family-backed service companies lack the external audit burden and technical barriers to entry inherent in metrology. This accreditation acts as both a license to operate and a switching-cost barrier, since clients must revalidate their supply chain when changing calibration vendors. The governance appears straightforward — owner-operator leadership by Bryan Taylor, with no outside board or institutional LP disclosure — suggesting a long-term hold strategy centered on technical reputation and steady-state cash generation.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Costa Mesa
Corporate office
Costa Mesa, CA, United States
Principals
Bryan Taylor
Founder
Frequently asked questions
Who runs day-to-day operations at InnoCal?
Bryan Taylor, the founder, oversees InnoCal as an owner-operator. The firm's leadership structure integrates quality-management responsibilities with laboratory oversight, consistent with the requirements of its ISO/IEC 17025 accreditation. No external general partners or non-family C-suite hires have been publicly identified.
Is InnoCal a diversified family office or a single operating business?
InnoCal appears to function as a single operating business that serves as the primary asset of the Taylor family. Public record does not disclose a portfolio of financial investments, fund commitments, or real estate holdings beyond the calibration laboratory. This makes it an operating-company centric family office rather than a diversified allocator.
What regulatory credentials does InnoCal hold?
InnoCal maintains ISO/IEC 17025 accreditation for its calibration laboratory, which is the international standard for testing and calibration competence. This accreditation is subject to regular surveillance audits by an accrediting body such as A2LA or NVLAP, and it is the credential that makes InnoCal's calibration certificates defensible during client FDA or FAA inspections.
Which industries form InnoCal's core client base?
InnoCal's laboratory serves heavily regulated sectors: medical-device manufacturing, pharmaceutical production, aerospace component testing, and industrial process control. These clients require NIST-traceable calibration with documented uncertainty budgets to satisfy quality-system auditors. The firm also supports university research labs and HVAC commissioning firms requiring precision thermal validation.
Does InnoCal pursue external growth capital or private equity investment?
No external investment or private equity backing has been disclosed for InnoCal. The firm operates without disclosed institutional partners, suggesting it is self-funded through retained earnings from its calibration-service revenue. The capital structure aligns with a family-held operating company that reinvests in laboratory equipment and technical staff.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: